Ligand field and polarity tuning of Fe( ii ) complexes for selective ROS-mediated anticancer activity
Chemical Communications · 2026 · 62 (33) · 8491-8495
DOI: 10.1039/d6cc00812g ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2026. Verfasst von Hyewon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Ferrous Compounds, Antineoplastic Agents, Coordination Complexes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Research Foundation of Korea, Shiv Nadar University.
Abstract (Originalsprache)
A redesigned N5-type ligand that strengthens the donating ability while reducing polarity was utilized to generate an Fe( ii ) complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Nanoscience, Ewha Womans University, Seoul, 03760, Republic of Korea.
- Graduate Program in Innovative Biomaterials Convergence, Ewha Womans University, Seoul, 03760, Korea.
- Department of Chemistry Education, Universitas Sanata Dharma Campus III, Yogyakarta, 55281, Indonesia.
Förderung
- National Research Foundation of Korea
- Shiv Nadar University
Zitieren
APA
Lee, H., Wijayanti, L. W., Park, H., & Hong, S. (2026). Ligand field and polarity tuning of Fe( ii ) complexes for selective ROS-mediated anticancer activity. Chemical Communications, 62(33), 8491-8495. https://doi.org/10.1039/d6cc00812g
Vancouver
Lee H, Wijayanti LW, Park H, Hong S. Ligand field and polarity tuning of Fe( ii ) complexes for selective ROS-mediated anticancer activity. Chemical Communications. 2026;62(33):8491-8495. doi:10.1039/d6cc00812g
BibTeX
@article{Lee2026,
author = {Lee, Hyewon and Wijayanti, Lucia Wiwid and Park, Hyungbin and Hong, Seungwoo},
title = {Ligand field and polarity tuning of Fe( ii ) complexes for selective ROS-mediated anticancer activity},
journal = {Chemical Communications},
year = {2026},
volume = {62},
number = {33},
pages = {8491--8495},
doi = {10.1039/d6cc00812g}
}
EUVIMED